Archives for October 12, 2004

← 2004

Niro, ISP link up on spray drying

Danish company Niro has forged closer links with US firm International Specialty Products to develop technologies aimed at enhancing the bioavailability of active pharmaceutical ingredients (APIs).

Fuji develops system for nucleic acid market

Fuji Photo Film has entered the worldwide nucleic acid extraction marketplace with a product which it claims can deliver DNA whole blood samples in as little as six minutes.

Mayne finds novel solution to aseptic production shortage

Pharmaceutical company Mayne Pharma has entered into a unique relationship with Birmingham's Aston University to create a cleanroom for aseptic production that could improve the delivery of drugs to the UK National Health Service and private medical...

Zambon, ObeTherapy start obesity collaboration

Italian pharmaceuticals company Zambon has linked up with France's ObeTherapy Biotechnology in a project to screen low-molecular weight drugs against a novel target in the treatment of metabolic disorders such as dyslipidaemia, metabolic syndrome and...

Collaboration boosts Canadian biotech sector

Laborium Biopharma and the Biotechnology Research Institute of the National Research Council (BRI-NRC) have entered into an alliance, further boosting the biomanufacturing sector of Montreal in Quebec, Canada.

Withdrawal of flu vaccine raises QA questions

The UK suspension preventing Chiron's export of Fluvirin took another twist yesterday after the biotech company became the subject of a US federal investigation over its reporting of the problems with the flu vaccine.

AstraZeneca delays diabetes drug

AstraZeneca has suffered another disappointment in its late-stage pipeline, with the news that the filing for approval of Galida (tesaglitazar), its new drug for diabetes, will be delayed by the need to carry out more studies.

Degussa to exit from food ingredients business?

Ending months of speculation, the flavours and texturants units at Degussa, Germany's third largest chemicals group, are up for sale as the firm looks at selling the food ingredients arm or finding a partner for its business.